search

Skip to results

Modify your search

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Select the operation between terms

AND

NOT

Edit your search term, change scope of search Enter search term

Full Text Keywords/Topics Title Author/Editor/ORCiD Abstract References/Bibliography

Availability

All content I have access to

Purchased
Free

NARROW

Format

Facet list

Journal Article (2)

Type

Facet list

Research Article (1)
Review Article (1)

Section

Clear

Find a Section

The list will update as you type

Facet list

POSTER PRESENTATIONS (7432)
Clinical: Therapy and observation (3583)
Clinical: Diagnosis and outcome (2010)
03. Poster presentations (1740)
Abstracts (1040)
Basic Science (1031)
Original Articles (1006)
Clinical: Therapy & observation (998)
c. Clinical: Therapy and observation (849)
Digital oral presentations (671)
Epidemiology (652)
Clinical: Diagnosis & outcome (595)
Regular Papers (520)
Original Article (446)
b. Clinical: Diagnosis and outcome (443)
Basic science (386)
Oral Presentations (380)
Letters to the Editor (369)
Microbiology (285)
a. Basic science (221)
Nurses presentations (210)
Genetics (156)
Nurses poster presentations (150)
EPIDEMIOLOGY (146)
d. Epidemiology (137)
Short reports (135)
Letter to the Editor (106)
Review Articles (104)
Digital oral poster presentations (99)
Editorial (95)
02. Digital oral presentations (90)
02. Digital oral presentation (89)
Review Article (87)
Short report (78)
01. Oral presentations (75)
Oral presentations (75)
04. Nurses presentations (67)
f. Microbiology (66)
b. Nurses poster presentations (61)
Editorials (60)
ECCO Fellowships & Grants (38)
ECCO Guideline/Consensus Paper (38)
Viewpoint (38)
oral presentations (38)
Poster presentations: 15:20–15:45: P3. Poster session: Monitoring of disease activity (37)
Poster presentations: 15:40–16:05: P6. Poster session: Treatment issues (33)
Corrigendum (31)
Corrigenda (30)
Scientific session 8: IBD Horizons (24)
e. Genetics (24)
supplement articles (24)
Crossing borders in IBD - Scientific Session 12: Awards & Closing Remarks (20)
Review Paper (20)
ECCO Scientific Workshop Paper (18)
Nurses oral presentations (18)
Poster presentations: 10:15–10:45: P1. Poster session: Innate/Adaptive Immunity, Microbiome and Genetics, how does it all connect? (17)
Poster presentations: 13:00–13:30: P2. Poster session: Epidemiology/registries (17)
ECCO Topical review (16)
Erratum (16)
Review Papers (14)
Poster presentations: 10:35–11:00: P4. Poster session: Growth and nutrition (12)
Viewpoints (11)
DOP Session 7 – Disease & therapy outcome (10)
ECCO Grant (10)
DOP Session 1 - Diet and bugs: The Folie à deux of IBD (9)
DOP Session 1 - Molecular profiling (9)
DOP Session 1 - Pathogenesis of IBD (9)
DOP Session 1 – Epithelial & cell biology (9)
DOP Session 1 – Imaging IBD: Endoscopy, radiology or histology? (9)
DOP Session 10 - Biomarker discovery in IBD (9)
DOP Session 10 - Fighting the F’s: Fat and fibrosis in IBD (9)
DOP Session 10 - New data from landmark studies (9)
DOP Session 10 – Clinical practice (9)
DOP Session 10 – The genome and microbiome (9)
DOP Session 10: Clinical IBD (9)
DOP Session 10: The Southern: Blocking (9)
DOP Session 10: Therapy: Biologics (9)
DOP Session 10: Translational IBD (9)
DOP Session 11 – Consequences (9)
DOP Session 11: Clinical Trials V (9)
DOP Session 12: Clinical Trials and Diagnostics (9)
DOP Session 13: Basic Science in IBD (9)
DOP Session 14: Diagnostics, Biomarkers (9)
DOP Session 15: Genetics and Multi-omics in IBD (9)
DOP Session 1: Basic Science in IBD 1 (9)
DOP Session 1: Clinical Trials I (9)
DOP Session 1: Epidemiology, environment and nutrition (9)
DOP Session 1: Quality measures, monitoring, modeling (9)
DOP Session 1: The Arctic: Epidemiology & Genetics (9)
DOP Session 2 - Altering disease outcome in IBD (9)
DOP Session 2 - Assessment of disease and therapy response (9)
DOP Session 2 - Revisiting imaging and endoscopy (9)
DOP Session 2 – Epidemiology of IBD (9)
DOP Session 2 – Genes, dysbiosis & function (9)
DOP Session 2: Clinical Trials II (9)
DOP Session 2: Clinical trials 1 (9)
DOP Session 2: Diagnostics and Outcomes (9)
DOP Session 2: New tips for clinical practice (9)
DOP Session 2: The Pacific: Imaging in IBD (9)
DOP Session 3 - Improving care of IBD (9)
DOP Session 3 - New biomarkers (9)
DOP Session 3 - Novel therapies in IBD (9)
DOP Session 3 – Epidemiology in practice (9)
DOP Session 3 – Safety first (9)
DOP Session 3: Biomarkers in IBD (9)
DOP Session 3: Epidemiology 1 (9)
DOP Session 3: Microbiology and Virology in IBD (9)
DOP Session 3: The Indian: IBD & COVID-19 (9)
DOP Session 3: Vedolizumab and ustekinumab therapies (9)
DOP Session 4 - From the bench to the crystal ball: Predicting outcomes with novel markers (9)
DOP Session 4 - IFX & IFX biosimilars (9)
DOP Session 4 - Optimizing surgery outcomes (9)
DOP Session 4 – Controlled & uncontrolled trials in IBD (9)
DOP Session 4 – Diagnosis: What's new? (9)
DOP Session 4: Basic Science in IBD 2 (9)
DOP Session 4: Immunogenicity and pharmacokinetics of biologics (9)
DOP Session 4: The Atlantic: Surgery & Outcome (9)
DOP Session 5 - Improving the care and outcome of IBD patients (9)
DOP Session 5 - Recent advances in epidemiology (9)
DOP Session 5 - Risks of disease, hazard of drugs (9)
DOP Session 5 – Children & adolescents (9)
DOP Session 5 – Drug levels & biomarkers (9)
DOP Session 5: Epidemiology and Environment (9)
DOP Session 5: Surgical treatment (9)
DOP Session 5: The Southern: Small molecules in IBD (9)
DOP Session 5: Therapy: Small Molecules (9)
DOP Session 6 - New insights into pathogenesis of IBD (9)
DOP Session 6 - Real-world evidence and pregnancy (9)
DOP Session 6 - Short- & long-term efficacy of biologics (9)
DOP Session 6 – Predicting outcome (9)
DOP Session 6: Clinical Trials III (9)
DOP Session 6: Clinical trials 2 (9)
DOP Session 6: Microbiology (9)
DOP Session 6: The Arctic: IBD Basic Science (9)
DOP Session 6: Towards personalised medicine (9)
DOP Session 7 - Comparing outcomes of biologic treatments for IBD (9)
DOP Session 7 - Managing children and adolescents with IBD (9)
DOP Session 7 - Simple tools to predict drug response and disease course (9)
DOP Session 7 – Monitoring therapy (9)
DOP Session 7: Clinical Trials IV (9)
DOP Session 7: Epidemiology 2 (9)
DOP Session 7: Genetics, Omics & Clinical trials (9)
DOP Session 7: Management of perianal and luminal disease (9)
DOP Session 7: The Pacific: Histology, artificial intelligence & more (9)
DOP Session 8 - Current and novel targets for IBD agents (9)
DOP Session 8 - Evolving therapeutic strategies (9)
DOP Session 8 - Pharmacokinetics of IBD therapies (9)
DOP Session 8 – Predicting remission & relapse (9)
DOP Session 8 – Thinking outside the box (9)
DOP Session 8: Basic Science in IBD 3 and beyond (9)
DOP Session 8: Clinical trials 3 (9)
DOP Session 8: Endoscopy in IBD: Assessment of activity and surveillance (9)
DOP Session 8: The Indian: Anti-TNF & Paediatrics (9)
DOP Session 8: Translational IBD (9)
DOP Session 9 - Pharmacokinetics, COVID and new classifications (9)
DOP Session 9 - Predicting IBD and IBD-related neoplasia (9)
DOP Session 9 - Treatments for drug failing patients (9)
DOP Session 9 – Basic science in IBD (9)
DOP Session 9 – Therapy today (9)
DOP Session 9: Clinical trials 4 (9)
DOP Session 9: Diagnostics and Fibrosis in IBD (9)
DOP Session 9: Endoscopy, Surgery, Genetics (9)
DOP Session 9: New therapies (9)
DOP Session 9: The Atlantic: Comparative effectiveness & Biomarkers (9)
ECCO Position statement (9)
Special article (9)
a. DOP Session 1 - Advances in IBD pathophysiology (9)
a. DOP Session 1: Current understanding Efficacy and safety of biologics (9)
b. DOP Session 2 - Mechanisms of intestinal inflammation (9)
b. DOP Session 2: IBD Genetics (9)
c. DOP Session 3: Old and new immunomodulators (9)
d. DOP Session 4 - Practicalities of IBD patient care (9)
d. DOP Session 4: Practicalities of IBD patient care (9)
e. DOP Session 5 - Old and new treatment (9)
e. DOP Session 5: Best surgical management of IBD (9)
f. DOP Session 6 - Novel treatments (9)
f. DOP Session 6: Optimisation of biologic therapies (9)
g. DOP Session 7 - Recent advances of biologic therapies (9)
g. DOP Session 7: Novel therapies (9)
h. DOP Session 8 - Intestinal healing (9)
h. DOP Session 8: Treatment strategies (9)
i. DOP Session 9 - Surgery and IBD (9)
i. DOP Session 9: Advances in IBD Pathophysiology (9)
j. DOP Session 10 - Clinical Epidemiology (9)
j. DOP Session 10: Microbes, food and cancer in IBD (9)
Correction (8)
DOP Session 10: Basic Science - Microbiology and more (8)
DOP Session 4: Diagnostics & Biomarkers (8)
DOP Session 4: Novel targets in IBD (8)
DOP Session 5: Basic Science (8)
DOP Session 6 – Surgical outcomes (8)
Sustainability in IBD and beyond - Session 10: Hot topics in IBD (8)
c. DOP Session 3 - Translational science in IBD (8)
Article (7)
Review (7)
Author Index (6)
Crossing borders in IBD: Session 4 - Balancing benefits and risks in 2024 throughout life (6)
Crossing borders in IBD: Session 8 - IBD Horizons (6)
Letter to the Editors (6)
Oral presentations: 14:00–16:30: O6. Treatment issues (6)
Scientific Session 4: IBD out of the gut (6)
Scientific Session 4: Modern monitoring of IBD (6)
Scientific Session 4: Optimising surgical outcomes (6)
Scientific session 7: Milestones in clinical care (6)
Sustainability in IBD and beyond - Session 8: IBD Horizons (6)
a. Nurses oral presentations (6)
Articles (5)
Crossing borders in IBD: Session 10 - Nutritional therapy - from paediatric to adult care (5)
Oral presentations: 11:15–12:30: O2. Epidemiology/registries (5)
Oral presentations: 14:00–16:30: O3. Monitoring of disease activity (5)
Poster presentations: 13:00–13:30: P5. Poster session: Surgery case discussions (5)
SPECIAL ARTICLES (5)
Scientific Session 10: Beyond the gut (5)
Scientific Session 10: Evolving goals (5)
Scientific session 5: Cartels in IBD (Part 1) (5)
Sustainability in IBD and beyond - Session 9: Basic Science: Novel genetic insights (5)
06. Late-Breaking Abstracts (4)
Crossing borders in IBD: Session 9 - Basic Science: Metabolism meets intestinal inflammation (4)
Index (4)
Late-Breaking Abstracts (4)
Oral presentations: 09:00–10:35: O4. Growth and nutrition (4)
Oral presentations: 09:00–11:15: O1. Innate/Adaptive Immunity, Microbiome and Genetics, how does it all connect? (4)
Regular articles (4)
Reviews (4)
Scientific Session 9: Basic Science: Big Data research (4)
Scientific Session 9: Basic Science: From basic science to practical approach (4)
Scientific Session 9: Basic Science: Milestones in Basic Science (4)
Scientific Session 9: Basic Science: The microbiome as game changer in IBD? (4)
Abstracts author index (3)
Crossing borders in IBD: Session 1 - IBD therapy - crossing borders (3)
Crossing borders in IBD: Session 11 - Clinical challenges / Cases (3)
Crossing borders in IBD: Session 2 - Defining targets for therapy in 2024 (3)
Crossing borders in IBD: Session 5 - Visualising IBD: ESGE-ECCO collaborative session on endoscopy (3)
Crossing borders in IBD: Session 6 - Revisiting Clinical trials in IBD (3)
ECCO Scientific Workshop Papers (3)
Oral presentations: 08:30–12:00: O7. Cases and Guidelines: when guidelines do not help (3)
Scientific Session 10.2: CD and UC: Similar disease burden and treatment goals? Is it the organ or the disease process? (3)
Scientific Session 10: Multidisciplinary cases (3)
Scientific Session 11: Fibrosis in IBD (3)
Scientific Session 11: Minimising malignancy risks: Clinical cases (3)
Scientific Session 11: Personalised medicine (3)
Scientific Session 11: What have we got outside our box of drugs? (3)
Scientific Session 1: Developing environmental recipes for IBD (3)
Scientific Session 1: Hot debates in IBD (3)
Scientific Session 1: Looking for the right sequence (3)
Scientific Session 1: Sophisticated strategies within reach (3)
Scientific Session 2: Can we do better with current drugs? (3)
Scientific Session 2: Keeping the patient at home: Is telemedicine the future? (3)
Scientific Session 2: Safety first? (3)
Scientific Session 2: When location makes the difference (3)
Scientific Session 4.1: Next generation diagnostics (3)
Scientific Session 4.2: Next generation diagnostics (3)
Scientific Session 5: Endoscopy as precision medicine approach to IBD - in collaboration with ESGE (3)
Scientific Session 5: Histology in IBD: What the gastroenterologist should know (3)
Scientific Session 5: The young and the old (3)
Scientific Session 6: Bottoms behaving badly (3)
Scientific Session 6: Cartels in IBD (Part 2) (3)
Scientific Session 6: Do we see light at the end of the fistula track? (3)
Scientific Session 6: Pain in IBD - in collaboration with ESNM (3)
Sustainability in IBD and beyond - Session 11: Emerging challenges (3)
Sustainability in IBD and beyond - Session 1: Sustainability in IBD Care (3)
Sustainability in IBD and beyond - Session 2: Novelties in IBD Care (3)
Sustainability in IBD and beyond - Session 4: Novel Monitoring Tools (3)
Sustainability in IBD and beyond - Session 5: Sustainable technology and consequences: ESGE-ECCO collaborative session on endoscopy (3)
Sustainability in IBD and beyond - Session 6: Surgical Sustainability (3)
05. Author Index (2)
Crossing borders in IBD: Session 3 - IBD care across the world (2)
Crossing borders in IBD: Session 7 - Gut brain axis - chicken or egg? (2)
ECCO Fellowship (2)
Errata (2)
Guidelines (2)
N-ECCO Grant (2)
Oral presentations: 11:30–12:40: O5. Surgery case discussions (2)
Retraction (2)
Reviews Articles (2)
Scientific Session 10.1: CD and UC: Similar disease burden and treatment goals? Is it the organ or the disease process? (2)
Scientific Session 3: Aiming high with treatment goals in IBD: The modern Icarus? (2)
Scientific Session 3: Hot and (almost) happening (2)
Scientific Session 3: Reducing the burden of IBD (2)
Scientific Session 3: Vascular complications of IBD: An overlooked problem (2)
Scientific Session 7: COVID and non-COVID infections (2)
Sustainability in IBD and beyond - Session 3: Sustaining remission - a joint effort (2)
Sustainability in IBD and beyond - Session 7: Nutritional News (2)
07. Corrigendum (1)
D-ECCO Grant (1)
ECCO Global Grant (1)
ECCO Pioneer Award (1)
EXPRESSION OF CONCERN (1)
IIS Registry Grant (1)
Mini-review (1)
Regular Paper (1)
Special Paper (1)
Systematic review (1)

Publication date

Date Range

Published
Updated

Date range

Single date

From Select month

To Select month

Publication date

1-2 of 2

Section: Guidelines

Save search

Follow your search

Access your saved searches in your account

Name your search

Follow this search

Would you like to receive an alert when new items match your search?

Save search

Sort by

Sort Order Select

Journal Article

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel Get access

PDF

Valerie Pittet and others

Journal of Crohn's and Colitis, Volume 7, Issue 10, November 2013, Pages 820–826, https://doi.org/10.1016/j.crohns.2013.04.013

Published: 01 November 2013

Journal Article

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease Get access

PDF

W. Miehsler and others

Journal of Crohn's and Colitis, Volume 4, Issue 3, September 2010, Pages 221–256, https://doi.org/10.1016/j.crohns.2009.12.001

Published: 01 September 2010

Advertisement intended for healthcare professionals

Email alerts

New journal issues

New journal articles

Perform this search in

Journals Journals

Books Books

ECCO Journals ECCO Journals

Oxford Academic Oxford Academic

Advertisement intended for healthcare professionals

Modify your search

Publication date

When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel Get access

A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease Get access

Email alerts

This Feature Is Available To Subscribers Only